Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Vasopressin V2 receptor antagonist beneficial in mouse model of PKD

Nov. 13, 1998

VPA-985 characterized as potent, selective, orally active V2 antagonist

Nov. 13, 1998

Sepracor announces results of phase II pilot trial for (S)-oxybutynin

Nov. 13, 1998

RenaGel available this month in the U.S.

Nov. 11, 1998

Alza focuses on urology products; licenses Urispas

Nov. 4, 1998

U.S. grants first approval for GelTex's novel phosphate-binding polymer therapeutic

Nov. 3, 1998

Synthelabo team presents new agents for incontinence

Nov. 3, 1998

Basis of beneficial effects of cactus flower in BPH

Oct. 30, 1998

Milkhaus successfully completes phase II trial of BPH therapeutic

Oct. 21, 1998

Celsion ready to begin BPH treatment studies

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...